Across TCGA pan-cancer cohorts, MIR1269A Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated MIR1269A data layer compared with 10 for mass-spec protein.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher MIR1269A Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR1269A expression acts as an unfavorable survival marker.

SKCM are the cancer types where MIR1269A Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Median	III,IV	0.040	0.613	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: MIR1269A tumor-vs-normal RNA expression · all MIR1269A data types